News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Heberlig Chris
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/17/2020 |
4
| Heberlig Chris (President and CFO) has filed a Form 4 on ORGANOVO HOLDINGS, INC.|
Txns:
| Granted 20,000 options to buy
@ $7.64, valued at
$152.8k
|
|
| 09/17/2020 |
3
| Heberlig Chris (President and CFO) has filed a Form 3 on ORGANOVO HOLDINGS, INC. |
| 09/19/2019 |
4
| Heberlig Chris (EVP & CFO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $8.83, valued at
$441.5k
|
|
| 03/06/2019 |
4
| Heberlig Chris (EVP & CFO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 46,000 options to buy
@ $17.92, valued at
$824.3k
|
|
| 09/24/2018 |
4
| Heberlig Chris (EVP & CFO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 45,000 options to buy
@ $30.93, valued at
$1.4M
|
|
| 05/29/2018 |
4
| Heberlig Chris (Exec VP & CFO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Converted 6,392 shares
@ $0
Bought 6,392 options to buy
@ $15.6438, valued at
$100k
Converted 74,935 options to buy
@ $0
Converted 6,392 options to buy
@ $0 |
|
| 05/23/2018 |
3
| Heberlig Chris (Exec VP & CFO) has filed a Form 3 on Kiniksa Pharmaceuticals, Ltd. |
| 06/23/2015 |
4
| Heberlig Chris (SVP, Finance & Business Ops.) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 56 shares
@ $78.87, valued at
$4.4k
Disposed/sold 446 shares
@ $0
Disposed/sold 24,000 shares
@ $0
Disposed/sold 82 options to buy
@ $0.95, valued at
$77.9
Disposed/sold 838 options to buy
@ $1.7, valued at
$1.4k
Disposed/sold 5,000 options to buy
@ $23, valued at
$115k
Disposed/sold 12,500 options to buy
@ $40.32, valued at
$504k
Disposed/sold 7,500 options to buy
@ $40.74, valued at
$305.6k
Disposed/sold 12,000 options to buy
@ $80.35, valued at
$964.2k
Granted 56 shares
@ $78.87, valued at
$4.4k
Disposed/sold 446 shares
@ $0 |
|
| 06/09/2015 |
4
| Heberlig Chris (SVP, Finance & Business Ops.) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 24,000 shares
@ $0 |
|
| 03/13/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/30/2014 |
4
| Heberlig Chris (Group Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 1,800 shares
@ $89.9, valued at
$161.8k
Sold 2,844 shares
@ $91.34, valued at
$259.8k
Sold 1,156 shares
@ $92.1, valued at
$106.5k
Sold 300 shares
@ $93.04, valued at
$27.9k
Exercised 1,100 options to buy
@ $1.7, valued at
$1.9k
Exercised 5,000 options to buy
@ $23, valued at
$115k
|
|
| 07/02/2014 |
4
| Heberlig Chris (Group Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 112 shares
@ $54.89, valued at
$6.1k
|
|
| 06/05/2014 |
4
| Heberlig Chris (Group Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 12,000 options to buy
@ $80.35, valued at
$964.2k
|
|
| 03/14/2014 |
4
| Heberlig Chris (Group Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 700 shares
@ $96.75, valued at
$67.7k
Sold 3,933 shares
@ $98.49, valued at
$387.4k
Sold 3,037 shares
@ $99.08, valued at
$300.9k
Exercised 1,850 options to buy
@ $1.7, valued at
$3.1k
Exercised 820 options to buy
@ $0.95, valued at
$779
Exercised 5,000 options to buy
@ $23, valued at
$115k
|
|
| 01/02/2014 |
4
| Heberlig Chris (Group Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 192 shares
@ $36.3, valued at
$7k
|
|
| 07/17/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2013 |
4
| Heberlig Chris (Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 12,500 options to buy
@ $40.32, valued at
$504k
|
|
| 10/19/2012 |
4
| Heberlig Chris (Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 2,000 shares
@ $49.64, valued at
$99.3k
Sold 2,000 shares
@ $49.67, valued at
$99.3k
Exercised 2,000 options to buy
@ $1.7, valued at
$3.4k
Exercised 2,000 options to buy
@ $0.95, valued at
$1.9k
|
|
| 09/06/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/29/2012 |
4
| Heberlig Chris (Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 15,000 options to buy
@ $40.74, valued at
$611.1k
|
|
| 06/05/2012 |
4
| Heberlig Chris (Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 800 shares
@ $35.5575, valued at
$28.4k
Sold 200 shares
@ $36.435, valued at
$7.3k
Exercised 1,000 options to buy
@ $0.95, valued at
$950 |
|
| 02/29/2012 |
4
| Heberlig Chris (Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 4,500 shares
@ $36.88, valued at
$166k
Exercised 4,500 options to buy
@ $0.95, valued at
$4.3k
|
|
| 01/11/2012 |
4/A
| Heberlig Chris (Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 15,000 options to buy
@ $23, valued at
$345k
|
|
| 12/22/2011 |
4
| Heberlig Chris (Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 15,000 options to buy
@ $23, valued at
$345k
|
|
| 11/10/2011 |
3
| Heberlig Chris (Vice President, Finance) has filed a Form 3 on SYNAGEVA BIOPHARMA CORP |
|
|